Catalyst Wire Dossier Catalyst Wire Dossier

MP-435

· Tanabe Pharma Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MP-435, covering 2014-10-13 to 2014-10-13. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of MP-435 in Combination With Methotrexate (MTX) in Patients With Rheumatoid Arthritis [Phase 2]

See pricing